Express detection and differentiation of M. tuberculosis and nontuberculous mycobacteria in samples Source: International Congress 2017 – MDRTB: detection and management Year: 2017
Genotyping of human Mycobacterium kansasii isolates from Poland. Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections Year: 2017
Clinical relevance of differentiation between Mycobacterium avium and M. intracellulare in M. avium complex pulmonary disease in Croatia Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019
Infection of the respiratory mucosa by Mycobacterium avium complex (MAC), Mycobacterium tuberculosis (MTB) and Mycobacterium smegmatis (MS) Source: Eur Respir J 2001; 18: Suppl. 33, 308s Year: 2001
Whole genome sequencing of Mycobacterium tuberculosis Source: Eur Respir J, 52 (5) 1801163; 10.1183/13993003.01163-2018 Year: 2018
Bedaquiline as a potential agent in the treatment of M. intracellulare and M. avium infections Source: Eur Respir J , 49 (3) 1601969; DOI: 10.1183/13993003.01969-2016 Year: 2017
Comparison of two commercial interferon-γ assays for diagnosing Mycobacterium tuberculosis infection Source: Eur Respir J 2006; 28: 24-30 Year: 2006
The spectrum of drug susceptibility of slow-growing nontuberculous mycobacteria (MAC, M. kansasii, M. xenopi) Source: International Congress 2017 – Clinical challenges in chronic lung diseases Year: 2017
DNA fingerprint analysis of Mycobacterium tuberculosis complex strains isolated from homeless tuberculosis patients in Budapest Source: Eur Respir J 2004; 24: Suppl. 48, 424s Year: 2004
Typing of Mycobacterium avium by various number tandem repeats (VNTR) analysis Source: Annual Congress 2006 - Epidemiology and management of multidrug-resistant tuberculosis (MDR-TB) Year: 2006
Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019
In vitro susceptibility of M. avium against protionamide Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions Year: 2011
Importance of identifying Mycobacterium bovis as a causative agent of human tuberculosis Source: Eur Respir J 2010; 35: 692-694 Year: 2010
Study of genetic heterogeneity in Mycobacterium tuberculosis isolates from tuberculosis patients using DNA fingerprinting Source: Eur Respir J 2005; 26: Suppl. 49, 655s Year: 2005
Mycobacterium avium complex infection: phenotypes and outcomesSource: Eur Respir J, 50 (3) 1701380; 10.1183/13993003.01380-2017 Year: 2017
Investigation of the inhibition of adherence of Mycobacterium avium complex (MAC) and Mycobacterium tuberculosis (MTB) to the respiratory mucosa Source: Eur Respir J 2001; 18: Suppl. 33, 480s Year: 2001
Analysis of mutations in multiple-drug-resistant M. tuberculosis strains isolated in Kyrgyzstan Source: Eur Respir J 2006; 28: Suppl. 50, 380s Year: 2006
Results of spoligotyping of M. tuberculosis strains isolated in Belarus Source: Annual Congress 2011 - Tuberculosis: from bench to bedside Year: 2011
Characteristics of drug susceptibility of M. abscessus subsp. abscessus and M.chelonae Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection Year: 2019
Can M. smegmatis be used as a real alternative for M. tuberculosis? Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR Year: 2016